The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

T-Mobile’s been battling with advertising regulators for months over those “save 20%” claims you’ve seen everywhere. The National Advertising Review Board (NARB) just concluded that T-Mobile failed ...

Please provide your email address to receive an email when new articles are posted on . The FDA said it will send letters to pharmaceutical companies asking for the removal of “misleading” drug ads.

The Food and Drug Administration (FDA) sent another warning to drug giant Novo Nordisk over an advertisement for weight loss drug Ozempic, saying the ad contains false and misleading claims. In a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Add Yahoo as a preferred source to see more of our stories on Google. (mcdustleroy/iStock Images) What is your reaction when viewing TV, listening to the radio or surfing digital platforms and there ...

Companies can sue for false advertising in various circumstances. If your company is facing revenue losses due to a competitor’s false or misleading statements or omissions in its advertisements, it ...

The British Advertising Standards Authority (ASA) has taken action against Hutch Games Ltd (F1 Clash), Kabam Games Inc (Marvel Contest of Champions) and Nexters Global Ltd’s (Hero Wars: Alliance RPG) ...

False and misleading advertising campaigns can have significant consequences for competitors. Whether a company’s deceptive practices relate to its own products or services, a competitor’s products or ...

Novo Nordisk has filed a lawsuit against Eli Lilly, accusing its fellow obesity drug titan of peddling false advertising claiming higher efficacy over respective obesity and diabetes products. In a ...

T-Mobile reached out with a stement regarding the situation, here’s what the company’s spokesperson said: “We disagree with the NARB’s conclusions. Over the course of this review, we engaged at every ...